News
-
-
PRESS RELEASE
Four Nines Gold to Present Hayden Hill Drill Program and Upcoming Catalysts at Emerging Growth Conference
President & CEO Charles Ross and VP Exploration David Flint to present at Emerging Growth Conference 95 on August 20, 2026, discussing advances in drilling at Hayden Hill and upcoming exploration catalysts -
-
-
-
-
-
-
PRESS RELEASE
The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon
NanoViricides, Inc. announces Phase II Clinical Trial of NV-387 Oral Gummies for Ebola viruses led by Prof. Patrick Katoto in DRC. Trial response to growing Bundibugyo outbreak -